Aperam's Stock Soars 20% in a Week, Two Analysts Recommend Buying
The steel specialist's stock rose 1.39% this Wednesday during the session, reaching 41.61 euros, following a very dynamic week with nearly a 20% increase over seven days. This surge comes as two banks consecutively upgraded their recommendations for the stock.
Analysts Upgrade Recommendations
This Wednesday, April 15, Jefferies upgraded its recommendation on Aperam from 'hold' to 'buy', with a price target set at 47 euros. At this level, the stock would still have a potential for approximately 13% growth from its current price of 41.61 euros. The day before, Deutsche Bank had raised its price target from 62 to 63 euros, while maintaining a buy rating. This target, significantly higher than the market price, reflects the German institution's confidence in the fundamentals of the Luxembourg-based group. These two revisions are part of a strong stock market dynamic for Aperam. The stock has shown a 15.39% increase over three months and nearly 59% over a year. The release of the first quarter 2026 revenue figures, expected on April 30, will be a next catalyst that could confirm or invalidate this momentum.
Technical Analysis of the Stock
Graphically, the price of 41.61 euros is now above the upper boundary of the Bollinger Bands, located at 40.84 euros, indicating a potential overbought zone. This breakout, while indicative of recent buying strength, suggests the need to watch for a possible short-term technical pullback. The stock is also above its 50-day moving average (38.26 euros) and far from its 200-day average (32.35 euros), confirming the bullish trend that has been underway for several weeks. The RSI at 65 remains below the conventional overbought threshold of 70, still leaving theoretical room for further advancement before the movement loses momentum. On the resistance side, the level of 43.12 euros is the next threshold to cross to extend the rise. In a contrasting European environment — the CAC 40 is down 0.52% in session while the DAX is almost stable — Aperam's performance stands out for its strength. The particularly low beta of the stock (0.19) also illustrates its relative decorrelation from major indices, a feature that distinguishes the stock within the materials sector. Among comparables, Imerys is modestly up by 0.28% while Eramet has fallen by 0.48%.
